Is an appropriate cutoff of hypertriglyceridemic waist designated for type 2 diabetes among Chinese adults?

Clinical Nutrition

Volumn 29, Issue 2, 2010, Pages 192-198

  Yu, Dahai ^a   Huang, Jianfeng ^a   Hu, Dongsheng ^b   Chen, Jichun ^a   Cao, Jie ^a   Li, Jianxin ^a  

^a FUWAI HOSPITAL   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

China; Diabetes mellitus; Hypertriglyceridemic waist; Impaired fasting glucose; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL VALUE; PHYSICAL ACTIVITY; PREVALENCE; SEX RATIO; WAIST CIRCUMFERENCE;

ADULT; AGED; AGING; BLOOD GLUCOSE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS; MALE; MASS SCREENING; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; REFERENCE VALUES; RISK FACTORS; SEX CHARACTERISTICS; STATISTICS AS TOPIC; URBAN POPULATION; WAIST CIRCUMFERENCE;

EID: 77950298557     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.06.008     Document Type: Article

References (33)

1. Muntner P., Gu D., Wildman R.P., et al. Prevalence of physical activity among Chinese adults: results from the International Collaborative Study of Cardiovascular Disease in Asia. Am J Public Health 2005, 95:1631-1636.
2. Gotto A.M. NCEP ATP III guidelines incorporate global risk assessment. Am J Manag Care 2003, 1(Suppl):3.
3. Gu D., Reynolds K., Duan X., et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003, 46:1190-1198.
4. Despres J.P., Lemieux I., Bergeron J., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
5. Hayashi T., Boyko E.J., McNeely M.J., Leonetti D.L., Kahn S.E., Fujimoto W.Y. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008, 57:1269-1275.
6. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the 'beef'?. Int J Obes (Lond) 2007, 31:1552-1553.
7. Lemieux I., Pascot A., Couillard C., et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 2000, 102:179-184.
8. He J., Gu D., Wu X., et al. Major causes of death among men and women in China. N Engl J Med 2005, 353:1124-1134.
9. Gu D., He J., Duan X., et al. Body weight and mortality among men and women in China. JAMA 2006, 295:776-783.
10. Reynolds K., Gu D., Muntner P., et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003, 21:1273-1281.
11. Allain C.C., Poon L.S., Chan C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20:470-475.
12. Myers G.L., Cooper G.R., Winn C.L., Smith S.J. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med 1989, 9:105-135.
13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-S20.
14. Blackburn P., Lemieux I., Lamarche B., et al. Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women. Diabetes Care 2008, 31:170-172.
15. Lebovitz H.E., Banerji M.A. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 2005, 28:2322-2325.
16. Alavian S.M., Motlagh M.E., Ardalan G., Motaghian M., Davarpanah A.H., Kelishadi R. Hypertriglyceridemic waist phenotype and associated lifestyle factors in a national population of youths: CASPIAN Study. J Trop Pediatr 2008, 54:169-177.
17. Lemieux I., Almeras N., Mauriege P., et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002, 18:725-732.
18. Vazquez G., Duval S., Jacobs D.R., Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007, 29:115-128.
19. Hara K., Matsushita Y., Horikoshi M., et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 2006, 29:1123-1124.
20. Misra A., Vikram N.K., Gupta R., et al. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond) 2006, 30:106-111.
21. Oizumi T., Daimon M., Wada K., et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Circ J 2006, 70:1663.
22. Koska J., Stefan N., Permana P.A., et al. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr 2008, 87:295-302.
23. Grundy S.M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28:629-636.
24. Gustafson B., Hammarstedt A., Andersson C.X., Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2276-2283.
25. Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
26. Wildman R.P., Gu D., Reynolds K., Duan X., He J. Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr 2004, 80:1129-1136.
27. Yang W., Reynolds K., Gu D., Chen J., He J. A comparison of two proposed definitions for metabolic syndrome in the Chinese adult population. Am J Med Sci 2007, 334:184-189.
28. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
29. Kotronen A., Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
30. Shankar S.S., Steinberg H.O. Weight loss and vascular function: the good and the unknown. Hypertension 2008, 52:57-58.
31. Reaven G. Age and glucose intolerance: effect of fitness and fatness. Diabetes Care 2003, 26:539-540.
32. Wildman R.P., Gu D., Reynolds K., Duan X., Wu X., He J. Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults?. Am J Clin Nutr 2005, 82:1195-1202.
33. Yoon K.H., Lee J.H., Kim J.W., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006, 368:1681-1688.